Zoltán Kaló

5.7k total citations · 2 hit papers
225 papers, 3.6k citations indexed

About

Zoltán Kaló is a scholar working on Economics and Econometrics, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Zoltán Kaló has authored 225 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 150 papers in Economics and Econometrics, 43 papers in General Health Professions and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Zoltán Kaló's work include Health Systems, Economic Evaluations, Quality of Life (136 papers), Pharmaceutical Economics and Policy (97 papers) and Healthcare cost, quality, practices (20 papers). Zoltán Kaló is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (136 papers), Pharmaceutical Economics and Policy (97 papers) and Healthcare cost, quality, practices (20 papers). Zoltán Kaló collaborates with scholars based in Hungary, United States and Netherlands. Zoltán Kaló's co-authors include András Inotai, Maarten J. IJzerman, Filip Mussen, John B. Watkins, Praveen Thokala, Stuart Peacock, Meindert Boysen, Kevin Marsh, Rob Baltussen and Nancy Devlin and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Lancet Oncology.

In The Last Decade

Zoltán Kaló

207 papers receiving 3.5k citations

Hit Papers

Multiple Criteria Decision Analysis for Health Care Decis... 2016 2026 2019 2022 2016 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zoltán Kaló Hungary 31 1.8k 577 528 358 281 225 3.6k
J. Chilcott United Kingdom 39 1.2k 0.6× 611 1.1× 547 1.0× 948 2.6× 211 0.8× 145 4.4k
Juan Marcos González United States 20 1.0k 0.6× 402 0.7× 233 0.4× 222 0.6× 107 0.4× 122 2.4k
Louis P. Garrison United States 41 3.1k 1.7× 1.1k 1.9× 924 1.8× 622 1.7× 405 1.4× 226 6.7k
Paul Grootendorst Canada 28 1.5k 0.8× 579 1.0× 328 0.6× 379 1.1× 42 0.1× 120 4.0k
M. Alan Brookhart United States 46 2.0k 1.1× 676 1.2× 528 1.0× 1.2k 3.4× 89 0.3× 152 9.2k
Brian Hutchison Canada 36 822 0.4× 1.8k 3.1× 567 1.1× 418 1.2× 353 1.3× 123 4.4k
Joseph S. Pliskin Israel 25 1.7k 0.9× 1.1k 1.8× 500 0.9× 437 1.2× 147 0.5× 107 4.5k
Stefanos Zenios United States 33 676 0.4× 364 0.6× 520 1.0× 345 1.0× 345 1.2× 67 3.3k
Marshall M. Joffe United States 45 710 0.4× 295 0.5× 833 1.6× 1.0k 2.8× 739 2.6× 113 8.5k
Richard A. Hirth United States 34 1.9k 1.0× 1.7k 3.0× 383 0.7× 762 2.1× 83 0.3× 133 4.7k

Countries citing papers authored by Zoltán Kaló

Since Specialization
Citations

This map shows the geographic impact of Zoltán Kaló's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zoltán Kaló with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zoltán Kaló more than expected).

Fields of papers citing papers by Zoltán Kaló

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zoltán Kaló. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zoltán Kaló. The network helps show where Zoltán Kaló may publish in the future.

Co-authorship network of co-authors of Zoltán Kaló

This figure shows the co-authorship network connecting the top 25 collaborators of Zoltán Kaló. A scholar is included among the top collaborators of Zoltán Kaló based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zoltán Kaló. Zoltán Kaló is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gamper, Eva‐Maria, Madeleine King, Anja Schiel, et al.. (2025). Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics. The Lancet Oncology. 26(5). 545–547. 1 indexed citations
2.
Kaló, Zoltán, et al.. (2024). The hidden burden of atopic dermatitis in central and Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research. 25(2). 257–264. 2 indexed citations
3.
Ahn, Jeonghoon, Iñaki Gutiérrez‐Ibarluzea, Michael Drummond, et al.. (2024). Value based healthcare and Health Technology Assessment for emerging market countries: joint efforts to overcome barriers. Expert Review of Pharmacoeconomics & Outcomes Research. 24(9). 1061–1066. 2 indexed citations
4.
Nagy, Balàzs, Ahmad Nader Fasseeh, Jonathan D. Campbell, et al.. (2024). Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models. Algorithms. 17(12). 546–546.
5.
Moukarzel, M, et al.. (2024). Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions. BMJ Open. 14(11). e090344–e090344. 1 indexed citations
6.
Pitter, János G., et al.. (2023). Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe. GeroScience. 46(2). 1807–1824. 17 indexed citations
7.
Elvidge, Jamie, Saskia Knies, Bertalan Németh, et al.. (2023). Health technology assessment of tests for SARS-CoV-2 and treatments for COVID-19: A proposed approach and best-practice recommendations. International Journal of Technology Assessment in Health Care. 39(1). e24–e24. 4 indexed citations
8.
Lorenzovici, László, Andrea Ildikó Gáspárik, Carsten Utoft Niemann, et al.. (2023). Systematic Literature Review of Economic Evaluations of Treatment Alternatives in Chronic Lymphocytic Leukemia. BioDrugs. 37(2). 219–233. 3 indexed citations
9.
McQueen, R. Brett, et al.. (2023). Multistakeholder Perceptions of Additional Value Elements for United States Value Assessment of Health Interventions. Value in Health. 27(1). 15–25. 15 indexed citations
10.
Németh, Bertalan, Maria Kamusheva, Antal Zemplényi, et al.. (2023). Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making. Journal of Comparative Effectiveness Research. 12(4). e220157–e220157. 2 indexed citations
11.
Kovács, Sándor, Zoltán Kaló, Katarzyna Kolasa, et al.. (2022). Implementation of coverage with evidence development schemes for medical devices: A decision tool for late technology adopter countries. Health Economics. 31(S1). 195–206. 8 indexed citations
12.
Lorenzovici, László, et al.. (2022). Burden of Chronic Heart Failure in Romania. Healthcare. 10(1). 107–107. 10 indexed citations
13.
Fasseeh, Ahmad Nader, et al.. (2020). Implementation of Health Technology Assessment in the Middle East and North Africa: Comparison Between the Current and Preferred Status. Frontiers in Pharmacology. 11. 15–15. 46 indexed citations
14.
Kaló, Zoltán, Antal Zemplényi, Maureen Rutten‐van Mölken, et al.. (2020). Development of transferability guidance for integrated care models with special focus on Central and Eastern European countries. Croatian Medical Journal. 61(3). 252–259. 6 indexed citations
15.
Csanádi, Marcell, et al.. (2019). Health Technology Assessment Implementation in Ukraine: Current Status and Future Perspectives. International Journal of Technology Assessment in Health Care. 35(5). 393–400. 14 indexed citations
16.
Csanádi, Marcell, Zoltán Kaló, Leoš Fuksa, et al.. (2018). The implications of external price referencing on pharmaceutical list prices in Europe. Health Policy and Technology. 7(3). 243–250. 15 indexed citations
17.
18.
Kolasa, Katarzyna, et al.. (2012). Role of health technology assessment in the process of implementation of the EU Transparency Directive: relevant experience from Central Eastern European countries. Expert Review of Pharmacoeconomics & Outcomes Research. 12(3). 283–287. 15 indexed citations
19.
Inotai, András, Zoltán Kaló, & I Boncz. (2012). Implications of economic crisis on health care decision-making in Hungary: An opportunity to change?. 20–26. 6 indexed citations
20.
Kaló, Zoltán, et al.. (2012). Cost-minimisation analysis of basal insulin analogues for treatment of type 2 diabetes. UCL Discovery (University College London).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026